AA
GMAB icon

Addison Advisors’s Genmab GMAB Stock Holding History

Addison Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.74K Sell
209
-86
-29% -$2.29K ﹤0.01% 476
2026
Q1 		$7.92K Sell
295
-5
-2% -$150 ﹤0.01% 686
2025
Q4 		$9.24K Hold
300
– – ﹤0.01% 636
2025
Q3 		$9.2K Hold
300
– – ﹤0.01% 642
2025
Q2 		$6.2K Sell
300
-84
-22% -$1.72K ﹤0.01% 683
2025
Q1 		$7.52K Buy
384
+113
+42% +$2.37K ﹤0.01% 622
2024
Q4 		$5.66K Sell
271
-97
-26% -$2.13K ﹤0.01% 651
2024
Q3 		$8.97K Buy
368
+251
+215% +$6.71K ﹤0.01% 606
2024
Q2 		$2.94K Sell
117
-56
-32% -$1.59K ﹤0.01% 681
2024
Q1 		$5.17K Sell
173
-105
-38% -$3.08K ﹤0.01% 567
2023
Q4 		$8.85K Buy
278
+83
+43% +$2.61K ﹤0.01% 526
2023
Q3 		$6.88K Buy
195
+137
+236% +$5.22K ﹤0.01% 517
2023
Q2 		$2.21K Buy
58
+36
+164% +$1.44K ﹤0.01% 563
2023
Q1 		$831 Sell
22
-28
-56% -$1.08K ﹤0.01% 589
2022
Q4 		$2.12K Buy
+50
New +$2.06K ﹤0.01% 554

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Addison Advisors's GMAB Position: Q2 2026 in Review

Addison Advisors reduced its Genmab (GMAB) stake by 29% in Q2 2026, selling an estimated $2.29K and leaving 209 shares worth $5.74K. The position accounts for ﹤0.01% of the portfolio, ranked #476.

Addison Advisors first reported a position in GMAB in Q4 2022 and has held it in 15 quarters since. The position peaked at $9.24K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Addison Advisors held 209 shares of Genmab worth $5.74K as of Q2 2026.
  • Addison Advisors sold 86 Genmab shares in Q2 2026, an estimated $2.29K.
  • Genmab made up ﹤0.01% of Addison Advisors's portfolio in Q2 2026, its #476 holding.
  • Addison Advisors first reported a position in Genmab in Q4 2022 and has held it in 15 quarters since.
  • Addison Advisors's Genmab position peaked at $9.24K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.